Hemoclassifying sera for ABO blood group system are used to ensure compatibility when transfusion. Anti-A murine hybridomas generation allowed a high quality, stability and availability hemoclassifying reagent formulation.. The replacement of national demand will let us save 200, 000 dollars annually by concept of importation replacement.

Hybridoma IHI-15 secretes anti-A which does not crossly react with other blodd goup antigens, recognizing the main groups as A and AB, as well as some weak A variants.

This reagent have been used in specificty, potence and avidity tests in labs of Gamma Biological Inc. of Texas, and in international workshops with the participation of laboratories of France, Japan, United States and Holland among others, being this product sobject of comparison to the commercial ones made in these countries

The product has a production license, health registration and a Cuban patent. Publications which back it up are presented in high impact journals.